ArticleMolecules (Basel, Switzerland)2026
Drug Release Behavior of Enrofloxacin Molecularly Imprinted Polymer Synthesized via Electron Beam Irradiation.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Traditional thermal polymerization for imprinted polymers suffers from long reaction time and initiator residues. This study proposes an initiator-free and fast reaction electron beam irradiation technique to synthesize enrofloxacin (ENRO) molecularly imprinted polymers (MIPs) for sustained drug release. ENRO-based MIPs were prepared using methacrylic acid (MAA) as a functional monomer and ethylene glycol dimethacrylate (EGDMA) as a crosslinker under electron beam irradiation within 2 h. The structure was characterized by SEM, FTIR, DSC, and TG. Drug loading capacity was determined via solvent elution, and drug release behavior was evaluated in simulated physiological environments. The MIP exhibited a high drug loading ratio of 13.27% and porous morphology (SEM). FTIR confirmed complete template removal, while thermal analysis indicated uniform drug dispersion and enhanced stability. Cumulative release was pH-dependent: 72.12% at pH 7.4 (physiological) and 41.67% at pH 1.2 (gastric). Drug release kinetics followed the Korsmeyer-Peppas model (R
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.